Building Biotechs
Global Collaboration and Clinical Trials with Dr. Denis Drygin, Pimera Therapeutics, Inc. Co-Founder
December 27, 2023
In this episode of Building Biotechs: A Podcast by Recruitomics Consulting, we’re joined by Dr. Denis Drygin, Co-Founder at Pimera Therapeutics, Inc. Come with us as we uncover Denis’ passion for RNA-targeting therapeutics, the serendipitous nature of drug discovery, and the importance of global collaboration for drugs development and clinical trials. We also discuss the challenges and fulfillment in drug development for a founder in the biotech industry.
Welcome to Building Biotechs: A Podcast by Recruitomics Consulting! We offer a behind-the-scenes look into the strategy for launching and scaling successful biotech and life science companies. 

Today, we chat with Dr. Denis Drygin, Co-Founder at Pimera Therapeutics., a private clinical-stage biotechnology company focused on developing breakthrough therapeutics for cancer and other primary unmet medical needs. Denis has a strong track record in the science world, leading the invention of the novel therapeutic approach "Selective Targeting of RNA Polymerase I Transcription (Pol I)." 

Topics we Discuss:

Subscribe here:

And connect with the hosts and guests here:

Building Biotechs: A Podcast by Recruitomics Consulting is handcrafted by our friends over at:

Previous guests include: Tiffany Summerville, Vice President of Human Resources at Sherlock Biosciences; Adam Thomas, Chief People Officer at Synlogic; Leslie Martin, Vice President of Talent Acquisition at Flagship Pioneering; Kevin E. Johnson, Human Capital Professional; Trice Alford, Chief Marketing Officer at Ronawk

Check out our three most downloaded episodes: